Leadership
Our team includes some of the world’s most respected oligonucleotide chemists, drug development experts, and dedicated patient advocates.
Executive Team
Paul Bolno, MD, MBA
President and Chief Executive Officer
Chris Francis, PhD
Senior Vice President, Corporate Development, Head of Emerging Areas
Daryn Lewis
Senior Vice President, Head of Human Resources
Anne-Marie Li-Kwai-Cheung, MChem, MTOPRA, RAPS
Chief Development Officer
Kyle Moran, CFA
Chief Financial Officer
Linda Rockett, JD
Senior Vice President, General Counsel
Sridhar Vaddeboina, PhD
Senior Vice President, Chemistry, Manufacturing, and Controls
Chandra Vargeese, PhD
Chief Technology Officer
Ginnie (Hsiu-Chiung) Yang, PhD
Senior Vice President, Translational Medicine
Board of Directors
Christian Henry, MBA
Chief Executive Officer, Pacific Biosciences
Paul Bolno, MD, MBA
President and Chief Executive Officer, Wave Life Sciences
Mark H. N. Corrigan, MD
Formerly Chief Executive Officer, Correvio Pharma Corp.
Peter Kolchinsky, PhD
Founder and Managing Partner, RA Capital Management L.P.
Aik Na Tan
Senior Vice President (Administration), Nanyang Technological University, Singapore
Adrian Rawcliffe
Chief Executive Officer, Adaptimmune Therapeutics plc
Ken Takanashi, MBA, CPA
Executive Vice President, Representative Director, Shin Nippon Biomedical Laboratories Ltd.
Gregory Verdine, PhD
Erving Professor of Chemistry, Harvard University and Vice Chairman, FOG Pharmaceuticals
Heidi L. Wagner, JD
Global Head of Government Affairs, ElevateBio, LLC